Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 98kWORD 24k
24 March 2015
Question for written answer E-004600-15
to the Commission
Rule 130
Norbert Lins (PPE)

 Subject:  Availability of homeopathic and anthroposophic medicinal products
 Answer in writing 

A report entitled ‘The Availability of Medicinal Products for Human Use’ was released on the website of the Commission’s Pharmaceutical Committee on 24 November 2014.

This report is a positive indication of the Commission’s interest in this area and also directs specific attention to the situation regarding the availability of homeopathic and anthroposophic medicinal products. It shows clear recognition of the increasing importance of this pharmaceutical sector and the specific problems it faces, clearly underlining the incomplete and slow implementation and enforcement of EU medicine legislation in this area.

Given that the report highlights the need to review the current EU pharmaceutical acquis in order to enhance the availability of homeopathic and anthroposophic medicinal products, can the Commission indicate:
What steps it intends to take to ensure that the specific problems facing the sector of homeopathic and anthroposophical medicinal products — especially the incomplete and slow implementation of EU medicine legislation — are addressed more effectively?
How it plans to use the report, which is intended to be used as input for ongoing policy discussions and developments?
Legal notice - Privacy policy